Literature DB >> 33653414

Severe acute respiratory syndrome coronavirus 2-induced acute aortic occlusion: a case report.

Artem Minalyan1, Franklin L Thelmo2, Vincent Chan2, Stephanie Tzarnas2, Faizan Ahmed2.   

Abstract

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 infection can lead to a constellation of viral and immune symptoms called coronavirus disease 2019. Emerging literature increasingly supports the premise that severe acute respiratory syndrome coronavirus 2 promotes a prothrombotic milieu. However, to date there have been no reports of acute aortic occlusion, itself a rare phenomenon. We report a case of fatal acute aortic occlusion in a patient with coronavirus disease 2019. CASE REPORT: A 59-year-old Caucasian male with past medical history of peripheral vascular disease presented to the emergency department for evaluation of shortness of breath, fevers, and dry cough. His symptoms started 5-7 days prior to the emergency department visit, and he received antibiotics in the outpatient setting without any effect. He was found to be febrile, tachypneic, and hypoxemic. He was placed on supplemental oxygen via a non-rebreather mask. Chest X-ray showed multifocal opacifications. Intravenous antibiotics for possible pneumonia were initiated. Hydroxychloroquine was initiated to cover possible coronavirus disease 2019 pneumonia. During the hospitalization, the patient became progressively hypoxemic, for which he was placed on bilevel positive airway pressure. D-dimer, ferritin, lactate dehydrogenase, and C-reactive protein were all elevated. Severe acute respiratory syndrome coronavirus 2 reverse transcription polymerase chain reaction was positive. On day 3, the patient was upgraded to the intensive care unit. Soon after he was intubated, he developed a mottled appearance of skin, which extended from his bilateral feet up to the level of the subumbilical plane. Bedside ultrasound revealed an absence of flow from the mid-aorta to both common iliac arteries. The patient was evaluated emergently by vascular surgery. After a discussion with the family, it was decided to proceed with comfort-directed care, and the patient died later that day. DISCUSSION: Viral infections have been identified as a source of prothrombotic states due to direct injury of vascular tissue and inflammatory cascades. Severe acute respiratory syndrome coronavirus 2 appears to follow a similar pattern, with numerous institutions identifying elevated levels of thrombotic complications. We believe that healthcare providers should be aware of both venous and arterial thrombotic complications associated with coronavirus disease 2019, including possible fatal outcome.

Entities:  

Keywords:  Aortic occlusion; COVID-19; Case report; Coronavirus; Thrombosis

Year:  2021        PMID: 33653414     DOI: 10.1186/s13256-021-02692-x

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  12 in total

1.  Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit.

Authors:  Luca Spiezia; Annalisa Boscolo; Christelle Correale; Nicolò Sella; Elisa Pesenti; Luca Beghetto; Elena Campello; Francesco Poletto; Lorenzo Cerruti; Marco Cola; Alessandro De Cassai; Laura Pasin; Serra Eugenio; Roberto Vettor; Anna Maria Cattelan; Paolo Simioni; Paolo Navalesi
Journal:  Thromb Haemost       Date:  2020-07-23       Impact factor: 5.249

Review 2.  The role of D-dimer testing in clinical hematology and oncology.

Authors:  Charles S Greenberg
Journal:  Clin Adv Hematol Oncol       Date:  2017-08

3.  Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US.

Authors:  Katherine A Auger; Samir S Shah; Troy Richardson; David Hartley; Matthew Hall; Amanda Warniment; Kristen Timmons; Dianna Bosse; Sarah A Ferris; Patrick W Brady; Amanda C Schondelmeyer; Joanna E Thomson
Journal:  JAMA       Date:  2020-09-01       Impact factor: 56.272

4.  Never ignore extremely elevated D-dimer levels: they are specific for serious illness.

Authors:  T Schutte; A Thijs; Y M Smulders
Journal:  Neth J Med       Date:  2016-12       Impact factor: 1.422

5.  A need for open public data standards and sharing in light of COVID-19.

Authors:  Lauren Gardner; Jeremy Ratcliff; Ensheng Dong; Aaron Katz
Journal:  Lancet Infect Dis       Date:  2020-08-10       Impact factor: 25.071

6.  Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy.

Authors:  Corrado Lodigiani; Giacomo Iapichino; Luca Carenzo; Maurizio Cecconi; Paola Ferrazzi; Tim Sebastian; Nils Kucher; Jan-Dirk Studt; Clara Sacco; Alexia Bertuzzi; Maria Teresa Sandri; Stefano Barco
Journal:  Thromb Res       Date:  2020-04-23       Impact factor: 3.944

7.  Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave.

Authors: 
Journal:  Thromb Res       Date:  2020-12-30       Impact factor: 3.944

8.  COVID-19 R0: Magic number or conundrum?

Authors:  Giulio Viceconte; Nicola Petrosillo
Journal:  Infect Dis Rep       Date:  2020-02-24

9.  COVID-19: what the clinician should know about post-mortem findings.

Authors:  Danny Jonigk; Bruno Märkl; Julie Helms
Journal:  Intensive Care Med       Date:  2020-11-03       Impact factor: 17.440

10.  WHO Declares COVID-19 a Pandemic.

Authors:  Domenico Cucinotta; Maurizio Vanelli
Journal:  Acta Biomed       Date:  2020-03-19
View more
  3 in total

Review 1.  COVID-19 and Peripheral Artery Thrombosis: A Mini Review.

Authors:  Ehsan Goudarzi; Fateme Yousefimoghaddam; Alireza Ramandi; Isa Khaheshi
Journal:  Curr Probl Cardiol       Date:  2021-09-24       Impact factor: 16.464

2.  Acute aortic occlusion associated with COVID-19: A rare complication of a not so rare disease.

Authors:  Ryan Lee; Robert Hsu
Journal:  J Am Coll Emerg Physicians Open       Date:  2022-04-29

3.  COVID-19-Induced Hypercoagulability: A Case Report.

Authors:  Bailey Sperry; Jenee Joseph; Benjamin Yglesias
Journal:  Cureus       Date:  2022-02-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.